SCHEMBL6736121

SCHEMBL6736121

O=C(Nc1c(Cl)cc(Cl)c(-c2nsc(C(F)(F)F)c2Cl)c1Br)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.36
MEN1 O00255 6/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
HTT P42858 1/20 0.36
ABL1 P00519 4/20 0.35
POLB P06746 3/20 0.33
LCK P06239 1/20 0.33
TYK2 P29597 1/20 0.33
DHODH Q02127 1/20 0.33
MAPK1 P28482 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 1/20 0.32
BMPR1B O00238 1/20 0.32
BMPR1A P36894 1/20 0.32
ACVR1B P36896 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6738940 0.84 TSHR (0.38) KMT2AMEN1LMNAPOLBALDH1A1
SCHEMBL6738983 0.79
SCHEMBL6735462 0.72
SCHEMBL6986419 0.71 KMT2A (0.38) KMT2AALDH1A1
SCHEMBL6741167 0.58 GAA (0.32)
SCHEMBL11136450 0.58 HPGD (0.58) KMT2AMEN1LMNASMN1; SMN2HPGD
SCHEMBL906788 0.57 HPGD (0.41) KMT2AMEN1LMNASMN1; SMN2HPGD
SCHEMBL15111368 0.57 KMT2A (0.47) KMT2AMEN1LMNASMN1; SMN2HPGD
SCHEMBL22430581 0.57 KMT2A (0.53) KMT2AMEN1LMNASMN1; SMN2HPGD
SCHEMBL6738206 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38425-E1 ANTICONVULSANTS ADMINISTERED ORALLLY UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES, INC. (CA) 2004-02-10 US claimed
US-5741818-A ANTICONVULSANTS UNIVERSITY OF SASKATCHEWAN (CA) 1998-04-21 US claimed
US-RE38425-E1 ANTICONVULSANTS ADMINISTERED ORALLLY UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES, INC. (CA) 2004-02-10 US disclosed
US-20040023807-A1 3-Arylisothiazoles and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2004-02-05 US disclosed
US-5741818-A ANTICONVULSANTS UNIVERSITY OF SASKATCHEWAN (CA) 1998-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023807-A1 3-Arylisothiazoles and their use as herbicides DDT, HAX1, SULT1E1 KMT2A 1009/4885MEN1 4560/4885LMNA 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.